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Omiganan pentahydrochloride (ILRWPWWPWRRK-NH2·5Cl) is an antimicrobial peptide currently in phase III clinical trials. This study aims
to unravel the mechanism of action of this drug at the membrane level and address the eventual protective role of peptidoglycan in cell walls. The
interaction of omiganan pentahydrochloride with bacterial and mammalian membrane models – large unilamellar vesicles of different POPC:
POPG proportions – was characterized by UV-Vis fluorescence spectroscopy. The molar ratio partition constants obtained for the two anionic
bacterial membrane models were very high ((18.9±1.3)×103 and (43.5±8.7)×103) and about one order of magnitude greater than for the neutral
mammalian models ((3.7±0.4)×103 for 100% POPC bilayers). At low lipid:peptide ratios there were significant deviations from the usual
hyperbolic-like partition behavior of peptide vesicle titration curves, especially for the most anionic systems. Membrane saturation can account for
such observations and mathematical models were derived to further characterize the peptide–lipid interaction under those conditions; a possible
relation between saturation and MIC was deduced; this was supported by differential quenching studies of peptide internalization. Interaction with
the bacterial cell wall was assessed using Staphylococcus aureus peptidoglycan extracts as a model. A strong partition towards the peptidoglycan
mesh was observed, but not as large as for the membrane models.
© 2007 Elsevier B.V. All rights reserved.Keywords: Antimicrobial peptide; Saturation; Partition; Membrane; Peptidoglycan1. Introduction
Omiganan pentahydrochloride (omiganan, sequence:
ILRWPWWPWRRK-amide·5Cl; predicted peptide charge at
neutral pH: 5+) is a novel cationic antibiotic peptide,
currently in phase III clinical trials, designed for topical use
to prevent catheter-related bloodstream infections and to
reduce bacterially induced acne lesions. The sequence of
omiganan is related to that of indolicidin, a ribosomally-
synthesized antimicrobial peptide (RAMP) that can be
purified from the granules of bovine neutrophils [1].
Besides its clinical importance – especially regarding the
prevention of nosocomial infections – omiganan could
become one of the first RAMP-related antibiotics to obtain
market approval.⁎ Corresponding author. Tel.: +351 21 7500931; fax: +351 21 7500088.
E-mail address: castanho@fc.ul.pt (M.A.R.B. Castanho).
0005-2736/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2007.02.005Omiganan demonstrated a broad spectrum of antimicro-
bial activity [2] and a favorable safety profile in clinical
trials for topical use [3,4]. However, the molecular bases
for these characteristics are still hypothetical and, like its
structural characterization, most information comes from
predictions based on studies of other RAMPs, namely the
related peptides indolicidin and CP-11 [4,5]. Moreover, as
with other RAMPs, bacteria exposed to omiganan seem to
be unable to evolve resistance even upon repeated expo-
sure [6,7]. This reflects the importance of the cellular
components that are targeted, which have been postulated
to either be the membrane or core metabolic pathways
such as protein or nucleic acid synthesis. Straightforward
membrane lysis, though, has been questioned as a
potential killing mechanism for both omiganan and indo-
licidin [4,8–10].
Bilayer and cell wall interactions might not be the only
microorganism killing processes of omiganan; nonetheless,
even if the peptide's main activity involves cytoplasmic
targets, such interactions with the membrane and cell wall
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these outer structures must necessarily be crossed. In
addition, because mammalian cells display profound differ-
ences relatively to prokaryotic ones [11,12], the interactions
of omiganan with membranes and cell walls of microorgan-
isms provide a potential step to improve target specificity.
Given this, the study of these interactions is essential to the
full rationalization of the macroscopic properties displayed
by omiganan.
While peptide–membrane interaction has been the subject
of many studies [13–17], the bacterial cell wall, especially
that of the Gram-positive bacteria, has been largely ignored
in what concerns the mechanisms of action of RAMPs or
RAMP-related antibiotics despite its likely role as a barrier
to their entry into the cell. The cell wall is mainly
constituted by an anionic peptidoglycan mesh with pore
sizes around 4 nm in diameter [18,19]; although the exact
topological disposition of the wall components is still under
debate [18–20] it is clear that larger peptides will not cross
it unchallenged [21,22]. Even for small peptides, such as
omiganan, the wall could potentially behave, if not as a
barrier, as an anionic trap.
Spectroscopic methodologies can yield detailed informa-
tion about several aspects of peptide interactions [23],
especially in the case of omiganan, which is intrinsically
fluorescent due to its four Trp residues; however, other
cellular constituents and processes often generate high
degrees of noise and interference. Resorting to model systems
is a workaround to these unwanted contributions: in this work
large unilamellar vesicles (LUVs), of varying anionic surface
charge, were used as models for both bacterial and
mammalian cell membranes. Because one of the main
differences between omiganan and indolicidin – which is
hemolytic – is the greater cationicity of the former, the
chosen models focus on the analysis of the charge effect,
rather than in specific interactions with membrane compo-
nents. In addition to the LUVs, a simple method was devised
using Staphylococcus aureus (S. aureus) peptidoglycan
extracts as a model system to clarify the omiganan–cell
wall interaction.
2. Materials and methods
2.1. Reagents and apparatus
Omiganan pentahydrochloride (purity >95%) was a kind gift from
MIGENIX, Inc. (Vancouver, Canada); 2-(4-(2-Hydroxyethyl)-1-piperazinyl)-
ethanesulfonic acid (HEPES), sodium chloride, chloroform, ethanol (spectro-
scopic grade) and acrylamide were from Merck (Darmstadt, Germany);
potassium iodide was from Riedel-de Haën (Seelze, Germany); 8-amino-
naphthalene-1,3,6-trisulfonic acid (ANTS) was from Invitrogen Corporation
(Carlsbad, California); 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol))
(POPG), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and 1,2-dipal-
mitoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (DPPG) were from Avanti
Polar-Lipids (Alabaster, Alabama); Cholesterol and Triton X-100 (TX-100)
were from Sigma (St. Louis, Missouri); S. aureus peptidoglycan extract was
from Fluka (Buchs, Switzerland) and the quenchers 5 and 16 NS (5- and 16-
doxylstearic acids, respectively) were from Aldrich Chem Co. (Milwaukee,
Wisconsin).Absorbance assays were performed in a Jasco V-560 UV-vis or a
Genesys 10 UV spectrophotometer; steady-state fluorescence assays were
performed in a SLM Aminco 8100 spectrofluorometer (equipped with a
450WXe lamp and double monochromators) or, for the studies of
omiganan–peptidoglycan interaction, in a SpectraMax GeminiEM microplate
spectrofluorometer (equipped with a 1 J/flash pulsed Xenon lamp). Time
resolved fluorescence measurements were as described elsewhere [24]. Lipid
films were dried overnight with a vacuubrand vacuum pump and extruded
afterwards.
All experiments were performed at room temperature and, unless
otherwise stated, all solutions prepared in a 10 mM HEPES buffer, pH 7.4,
containing 150 mM NaCl, which is expected to mimic physiological
conditions. All steady-state omiganan fluorescence measurements were taken
at an excitation wavelength of 280 nm, except for the experiments
involving acrylamide where, to minimize inner filter effects due to its
absorption at 280 nm, the samples were excited at 295 nm. Emission
spectra were collected in the 300–450 nm wavelength range. When full
spectra were not taken, single wavelength measurements were read at
353 nm in the absence of lipids and at 343 nm otherwise. ANTS
fluorescence was taken by exciting at 360 nm and recording the emission at
500 nm.
2.2. Preparation of model systems
For the production of membrane model systems LUVs were prepared by
extrusion of hydrated phospholipids through 400 and 100 nm pore
membranes, as described elsewhere [25]; biological model systems include
100% POPC LUVs as well as 1:4, 2:1 and 4:1 POPG:POPC LUVs; the same
models, except for the 2:1 proportion, were also prepared with cholesterol in a
1:2 cholesterol:phospholipid ratio. Other studied LUVs were 100% POPG,
100% DPPC and 100% DPPG systems. To produce ANTS loaded vesicles
LUVs were prepared in the described buffer with the addition of 10 mM
ANTS; the resulting LUVs were then passed through a 10 mL Bio-Rad
Econo-Pac 10DG column (Bio-Gel P-6DG gel with 6 kDa molecular weight
exclusion).
To prepare the bacterial wall model systems, peptidoglycan extracts were
first softly mashed with a glass rod and then suspended in buffer. The
mashing was necessary to de-aggregate some larger particles of the
lyophilized extracts powder that would render the suspension inhomogeneous.
2.3. Photophysical characterization in bulk aqueous phase
The linear dependence of the absorbance and fluorescence intensity of
omiganan on its concentration was tested over the 0–14.5 μM range. To
check whether aggregation occurs in the aqueous phase aliquots of a 4 M
acrylamide solution were sequentially added to a peptide sample while
recording both the absorbance and fluorescence intensity. In this, and in
all subsequent studies where a constant peptide concentration was
required, 7.7 μM omiganan was used as a working concentration; this
concentration is both biologically relevant – it is within the range of the
MICs of omiganan against a number of strains [2] – and spectroscopically
adequate – it is high enough to provide a strong fluorescence signal while
having an absorbance under 0.1 at 280 nm, which ensures minimal inner
filter effects.
2.4. Membrane interaction studies
The extent of membrane partition to each modeled system was
determined by adding small aliquots of a LUV suspension to a peptide
sample and recording its fluorescence spectrum. Membrane saturation points
were determined by adding aliquots of a 205.3 μM stock peptide solution
to a suspension of LUVs, in the presence of 300 mM acrylamide, and
recording the fluorescence; to prevent acrylamide dilution the stock solution
was also prepared with 300 mM acrylamide.
Differential quenching studies were carried out by sequentially adding
aliquots of a lipophilic quencher – either 5-NS or 16-NS – to a LUV
suspension previously equilibrated with peptide; for each modeled system two
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saturation states and quencher concentration was increased or reduced
accordingly; both steady-state and time resolved measurements were taken
(the latter only on the first and last points). Because the 5- and 16-NS stock
solutions were prepared in ethanol, care was taken, while adding the quencher
aliquots, to keep final ethanol concentrations below 2% (v/v) in order to
prevent bilayer alterations [26].
For every addition in the described procedures, a minimum of 10 minutes
was allowed for incubation before measurement.
Peptide induced leakage of vesicle contents was tested by sequentially
adding 400 mM KI and 7.7 μM omiganan to ANTS containing vesicles; the
ANTS fluorescence quenching by iodide was monitored (excitation at 360 nm
and emission at 500 nm) and maximum leakage was assumed to be achieved by
addition of 0.2% (v/v) Triton-X100.
2.5. Peptidoglycan interaction study
Different volumes of a peptidoglycan suspension were added to separate
samples of omiganan at the working concentration and allowed to equilibrate for
10 minutes. The samples were then centrifuged at 4300 g for 5 minutes and the
supernatant was recovered for fluorescence recording. Blanks were prepared in
the same conditions but in the absence of peptide to correct for the fluorescence
interference from leftover peptidoglycan in suspension.Fig. 1. Partition curves of 7.7 μM omiganan in several lipidic systems; fitted
parameters are summarized in Table 1. The solid lines represent the fitting of the
data to a partition model. Data points were connected to better evidence
deviations from a hyperbolic behavior. (A) 100% POPC (▵) and 100% DPPC
(○) systems; data were fitted to the simple partition model (Eq. (1)) or to the
self-quenching model (Eq. (2)), respectively. Due to possible bilayer saturation,
the second and third points of the POPC partition curve were left out of the
fitting. (B) 100% POPG (▵) and 100% DPPG (○) systems; data were fitted to
the simple partition model (Eq. (1)), but only the last four points of the POPG
curve and the last three of the DPPG curve were used in the fit. (C) POPG:POPC
4:1 system. Data were fitted to the simple partition model (Eq. (1)), but only the
rightmost 5 points were used for the fit. Partition towards POPG:POPC 2:1
LUVs (not shown) behaved similarly to the POPG:POPC 4:1 system, while for
the POPG:POPC 1:4 system fitting to any of the models was not possible.3. Results
3.1. Photophysical characterization in bulk aqueous phase
The spectroscopic behavior of omiganan in aqueous solution
resembled that of Trp, in respect to both absorbance and
fluorescence (data not shown); linearity between absorbance
and fluorescence intensity was observed up to 14.5 μM. The
calculated absorptivity coefficient (ε) of omiganan at 280 nm
was 1.72×104 M−1 cm−1, yielding a molar absorptivity per Trp
residue of 4.3×103 M−1 cm−1. The quenching of omiganan by
acrylamide also followed a linear Stern–Volmer relationship,
with a KSV of 15.5 M
−1. Static quenching by acrylamide
originated slight upward deviations from linearity above
300 mM of quencher.
3.2. Membrane incorporation studies
Upon the partitioning of omiganan to vesicles there was,
generally, an increase in fluorescence intensity as well as a
spectral shift of about 10 nm to lower wavelengths (not shown).
For the neutral, liquid-ordered POPC system, the increase in
intensity followed a hyperbolic-like relationship, whereas the
gel-phase DPPC system deviated from that behavior, inducing
an intensity decrease at low concentrations, followed by a
sigmoidal rise (Fig. 1A).
A deviation, or spike, in the fluorescence intensity vs. lipid
concentration relationships was observed at low lipid concen-
trations for the most anionic systems (100% POPG, 100%
DPPG, 4:1 POPG:POPC and 2:1 POPG:POPC systems) (Figs.
1B and C, and 3A; 2:1 POPG:POPC system not shown). This
was not observed in the less anionic 1:4 POPG:POPC system
(not shown).
Cholesterol enriched systems displayed sigmoidal curves
(Fig. 2), with a behavior similar to the one displayed by the
DPPC system (Fig. 1A).Membrane saturation points were successfully obtained for
the 4:1 POPG:POPC system (Fig. 3B) and for the 2:1 POPG:
POPC system (not shown): in a titration of vesicles with
omiganan, at low peptide concentrations, a linear relationship
between fluorescence intensity and peptide concentration was
Fig. 3. (A) Partition curves of 4.1, 8.2, 12.8 and 25.7 μMomiganan in 4:1 POPG:
POPC. Saturation points were taken as the maximum of the deviation in each
curve and were used to determine the saturation ratio and the partition constant
(Fig. 6). There is an approximately common behavior of the curves after the
deviations, which is in agreement with the simulated partitions. A curve with
1.0 μM omiganan was also obtained (not shown), but a much higher IL/IW ratio
was observed; its Kp, however, was similar to the others'. Average Kp and IL/IW
ratio (Table 1) are in agreement with the already obtained constant and ratio for
the same system (Fig. 1C). (B) Titration of different phospholipid concentrations
with omiganan (4:1 POPG:POPC system) in the presence of 300mMacrylamide.
Saturation points were identified from the breaks in each curve. The dotted line
indicates the peptide concentration at which the partition curve in Fig. 1C has a
relative maximum (around 0.040 mM of phospholipid); this peptide concentra-
tion is very close to the saturation point in the 0.040 mM phospholipid curve.
Fig. 2. Partition curves of 7.7 μM omiganan for the cholesterol containing
systems; solid lines represent the fitting of the data to one of the described
models. (A) 100% POPC (▵) and 1:4 POPG:POPC (○) systems—because
there is a clear deviation of the partition behavior towards that of the DPPC
system (Fig. 1A) Eq. (2) had to be used to fit the 100% POPC system; Eq.
(1) was used for the 1:4 POPG:POPC fit. Obtained partition constants are
summarized in Table 1. (B) 4:1 POPG:POPC system—a distended and
sigmoidal behavior was induced by cholesterol, although a deviation still
occurred; because the remaining data points (two further phospholipid
concentrations were used) lie almost horizontally, no information on the
partition extent could be extracted.
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on the used lipid concentration, a break occurred in the graph
and a second linear regime, with a lower slope, followed. These
breaks were assumed to represent membrane saturation, as
discussed below. For the other less anionic systems, saturation
points were impossible to determine since the curves did not
display a clear break, although their slopes did decrease with
increasing peptide concentration (data not shown).
In the membrane localization studies all biological model
systems performed similarly in that relative quenching efficien-
cies by 5-NS and 16-NS were the same regardless of the
membrane surface charge (Fig. 4). The time dependent
fluorescence data were in agreement with the steady state
measurements concerning 5- and 16-NS relative quenching
efficiencies. The greatest observed differences were not between
different systems, but between saturated and non-saturated states
within the same system: the quenching efficiency of both
quenchers was similar in non-saturated states whereas a clear
increase of 16-NS quenching efficiencywas observed in saturated
systems (Fig. 4).3.3. Omiganan induced leakage of vesicle contents
Omiganan did not seem to induce any kind of bilayer
perturbation strong enough for membrane crossing by either
ANTS molecules or iodide that would result in a decrease in
the encapsulated ANTS fluorescence (not shown). The
methodology was tested using as a control a peptide that
induced leakage.
3.4. Peptidoglycan interaction study
After centrifugation of the peptidoglycan, a decrease in
supernatant fluorescence, with increasing peptidoglycan
concentrations, was observed (Fig. 5). This indicates that
part of the peptide was dragged along with the mesh and
that there is interaction between the two.
Fig. 5. Normalized omiganan fluorescence after incubation with several
concentrations of peptidoglycan extracts, physically separated by centrifugation.
The data were fit (solid line) to a single parameter model (Eq. (9)) and aDg value
of 15.9±1.1 mL/mg (Dv= (3.1±0.2)×10
3) was obtained.
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4.1. Photophysical characterization in bulk aqueous phase
The observed behavior of omiganan in aqueous phase did
not reveal the presence of significant peptide–peptide interac-
tions at the used concentrations: the obtained molar absorptivity
is close to the one of free Trp+ (5.6×103 M−1·cm−1 [27]). The
linear Stern–Volmer plot is indicative of no Trp side chain
inaccessibility, the occurrence of which could be associated to
peptide aggregation [28], and is also in agreement with the
absence of Trp side chain protection since the KSV for
acrylamide quenching of free Trp+ is 15.8 M−1 [29].
4.2. Membrane incorporation studies
The procedures for the membrane incorporation quantifica-
tion were designed to allow the calculation of the NernstFig. 4. Stern–Volmer representations (I0/I vs. quencher concentration) of the
quenching of 7.7 μM omiganan by the membrane quenchers 5- and 16-NS
(○ and● symbols, respectively), in the 4:1 POPG:POPC system (the quenching
behavior in this system is representative of what was obtained for 2:1 and
1:4 POPG:POPC and 100% POPC systems). (A) Membrane saturation was
induced by using 0.030 mM of phospholipid. (B) A phospholipid concentration
of 0.3 mM was used to avoid saturation. Effective quencher concentration in the
membrane was calculated using the partition constants provided by Wardlaw
et al. [49]. The increase in the difference of 16-NS and 5-NS quenching
efficiencies in A relatively to B is indicative of peptide burying in the bilayer,
although only an average localization can be inferred, as there are four Trp
residues in omiganan.partition constant (Kp) from fluorescence intensity (I) vs.
phospholipid concentration ([L]) plots, at a constant peptide
concentration ([P]), by a simple partition model, described by
Santos et al. [30]. The partition constant is the ratio between
the equilibrium membrane-bound and aqueous phase peptide
concentrations1 [30], thus providing an easy assessment of the
extent of membrane interaction. The model used in this study
regards the membrane as a volume of a separate lipidic phase
within the bulk aqueous phase and treats the peptide–
membrane interaction as a Nernst equilibrium; the fluorescence
intensity of a peptide–lipid system, normalized by the
fluorescence intensity of the peptide in aqueous phase, is
then given by Eq. (1) (adapted from [30]):
I=IW ¼ 1þ KpgL½LIL=IW1þ KpgL½L
; ð1Þ
where [L] is the total phospholipid concentration available for
the peptide to interact with, Kp is the Nernst partition constant
and γL is the phospholipids molar volume, which is 0.763
M− 1 for liquid crystal phases [31] and 0.689 M− 1 for gel
phases [32]. IL and IW are the fluorescence intensities the
mixture would display if all the peptide was in the lipidic or
aqueous phase, respectively. IW can be readily obtained from
the measurement of I in the absence of lipid; IL, however, is a
limit value of fluorescence intensity as [L]→∞ and is
determined as a system parameter together with Kp.
21 Note that, as remarked by Santos et al., care must be taken when
intercomparing Kp data from the literature since some authors define the
partition constant as the ratio between the lipid and aqueous phase solute
concentrations whereas others define it as the ratio between the molar fractions
of the solute in each phase. Approximate conversion can be obtained by using
Kp=Kp,x·γW/γL, where Kp and Kp,x are the concentration ratio and the molar
fraction ratio partition constants, and γW and γL stand for the aqueous and
lipidic phases molar volumes [30].
2 More accurately, IL should be attained when [L] reaches its maximum value
of 1/γL, which corresponds to a phospholipid only solution; for most practical
cases, however, this amounts to a negligible correction. Further considerations
on the subject can be found in [33].
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curve’, is thus expected to be hyperbolic-like and independent
of the initial peptide concentration in an ideal partition. An
issue to bear in mind is that, because fluorescence emission
spectral shifts can also be a consequence of peptide–lipid
interaction, the integrated spectral intensity should be preferred
over single wavelength intensity. In this work, full spectra were
always used when possible, although the differences between
following that approach and using a single wavelength were
rarely significant.
In the present case, a difference between IW and IL was
expected to occur as a consequence of an alteration in the Trp
environment as the peptide enters the membrane [23,30].
4.2.1. Neutral systems
For the liquid-ordered phase POPC vesicles, which were
used to model the outer leaflet of the mammalian membrane
(the inner leaflet was modeled with a 1:4 POPG:POPC system),
there was a good agreement of the partition curve (Fig. 1A) with
the partition model, from which a Kp value of (3.7±0.4)×10
3
and a IL/IW ratio of 3.09±0.11 were obtained (partition
parameters obtained for all lipidic systems are summarized in
Table 1). For the gel phase neutral DPPC LUVs, which were
used for the sake of studying the influence of membrane
rigidity, initial deviations did not allow the fitting of the simple
partition model (Fig. 1A). However, the intensity drop,
followed by a somewhat sigmoidal behavior, was consistent
with the phenomenon of peptide self-quenching: this effect is
related to the accumulation of peptide molecules in membrane
line defects on the borderlines between different phospholipidic
crystalline organizations, favored by the rigidity of the gelTable 1
Summary of the characteristics of each modeled system: constitution, partition para
Modeled system Constituent phospholipids a
100% Neutral Membrane gel phase DPPC
100% Anionic membrane gel phase DPPG
100% Anionic membrane liquid crystal phase POPG
Bacterial membrane models
Inner leaflet d 4:1
Inner leaflet+cholesterol e, f 4:1
Outer leaflet 2:1
Mammalian membrane models
Inner leafletf 1:4
Inner leaflet+cholesterol e 1:4
Outer leaflet POPC
Outer leaflet+cholesterol e POPC
a POPG:POPC mixtures are indicated by the proportion between phospholipids. A
b Used model for the fitting of the experimental results—SP: ‘Simple Partition’, the
formalism described by Henriques and Castanho (Eq. 2) was used.
c Occurrence (+), or not (−), of an upward deviation in the partition curve, for low
d The parameters for this system are the average of the results of several partition c
1.0 mM curve (not shown) was not included.
e The system is also constituted by cholesterol in a 1:2 molar proportion relativel
f The extraction of partition parameters by curve-fitting was not possible for this sys
or ‘n.a.’ (not applicable), according to each case.phase DPPC bilayers. Eq. 1 was adapted, as deduced by
Henriques et al. [34], becoming
I
IW
¼ KpgL½LIL=IW
1þ KpgL½L þ k2KpIL
þ 1
1þ KpgL½L
; ð2Þ
where k2 is proportional to the ratio between the bimolecular self-
quenching rate and the radiative decay rate. Note that the limit as
[L]→∞ is not altered by the occurrence of self-quenching or by
differences in the initial peptide concentration. The partition
constant determined by this method was of (4.9± 0.3)×103 and
the IL/IW ratio was of 1.80±0.03. While theKp is close to the one
obtained for the POPC system, the IL/IW ratio points towards a
slightly different peptide conformation/localization.
The partition of omiganan to the neutral lipidic systems was
very strong despite the absence of negative surface charge on the
vesicles. Although electrostatic interactions can be expected to
play a significant role in the activity of omiganan due to its 5+
charge, it was seen that the hydrophobic effect and van der Waals
forces that dominate the partition to the neutral systems can
account for an important part of the peptide's membrane
interaction. Hydrophobic residues such as Ile and Leu and an-
choring residues such as Trp may play an important role in par-
tition under these conditions.4.2.2. Anionic systems
Accurate determination of the partition constant in systems
containing anionic phospholipid was difficult or impossible,
due to large deviations from either hyperbolic or sigmoidal
partition curves (Fig. 1B and C): at variance with the partition
to the neutral systems, the initial points of both liquid crystalmeters and initial behavior of the partition curve
Kp/10
3 IL/IW Used model
b Initial deviation c
4.9±0.3 1.80±0.03 SQ –
12.5±0.8 1.58±0.01 SP +
14.6±1.3 1.76±0.01 SP +
23.0±0.7 1.94±0.06 SP +
n.o. n.o. n.a. +
43.5±8.7 1.84±0.04 SP +
n.o. n.o. n.a. −
1.8±0.2 2.89±0.09 SP −
3.7±0.4 3.09±0.11 SP +
8.2±1.2 2.08±0.14 SQ −
ll other systems are constituted by a single type of phospholipid.
formalism described by Santos et al. was used (Eq. 1); SQ: ‘Self-Quenching’, the
phospholipid concentrations.
urves at different peptide concentrations (Figs. 1C and 3A). The IL/IW ratio of the
y to the phospholipids.
tem. Fields depending on this information are marked either ‘n.o.’ (not obtained)
1283M.N. Melo, M.A.R.B. Castanho / Biochimica et Biophysica Acta 1768 (2007) 1277–1290and gel phase partition curves seem to overshoot above a
hypothetical hyperbolic behavior, returning to it at higher lipid
concentrations, closer to the curve plateau. Nonetheless, the
partition of omiganan towards these vesicles seems to be greatly
enhanced relatively to their neutral counterparts, judging by the
very high initial slopes of the partition curves and the little
amount of lipid required to reach almost maximal interaction
(notice the difference in the x axis scale of Fig. 1B and C
relatively to Fig. 1A). Such an increase in the partition extent
was expected because electrostatic interactions are very likely to
affect the heavily charged peptide; in addition, it is possible that
this very strong partition is responsible for the observed
deviations from the partition model. Namely, membrane
saturation may occur at low lipid concentrations when the
bound peptide concentration hypothetically dictated by Kp is
higher than what the membrane can accommodate. Because it
considers the peptide as a volumeless entity, and thus incapable
of saturating the lipidic phase, the model of Santos et al. [30] is
not suited to the study of saturated systems and other models,
described below, were devised to better characterize these
situations. From the partition curves, Kp values could be
extracted by fitting only the non-saturated points to the simple
partition model (Fig. 1, Table 1). Statistical significance was, of
course, hurt by this approach both because the number of
available data points was reduced and because the initial rising
portion of the hyperbolic partition curve, which was absent, is
determinant in the calculation of Kp. Nevertheless, the obtained
partition constants (Table 1), which are greater than those of the
neutral systems, are consistent with the expected role of the
electrostatic interactions (the partition towards the 1:4 POPG:
POPC system – not shown – could not be fitted but was visibly
less intense than for the other anionic systems). The same charge
relationship was observed for the related peptide indolicidin
[35]. The occurrence of these deviations and the hypothesis that
they could represent a phenomenon not described by the simple
partition model led to the discarding of the second and third
points when fitting the POPC partition curve (Fig. 1A), which,
upon closer inspection, seem to also deviate from the hyperbole.
The different obtained Kp's are indicative of a strong
preference of omiganan towards negatively charged membranes
similar to the bacterial systems (2:1 and 4:1 POPG:POPC
systems, which are as anionic as the outer and inner bacterial
cell membrane leaflets [11,12]), which appear to induce the
highest extents of partition by providing an optimal negative
surface charge. This selectivity/affinity of omiganan for
prokaryotic bilayer membranes is thus one possible factor for
the favorable safety profile of omiganan as a topical drug [3]:
the peptide's concentration in a zwitterionic mammalian
membrane does not get as high as in an anionic bacterial
membrane. Partition constants of such magnitudes are com-
monly displayed by membrane-active peptides ([36,37] note
that intercomparison of different partition constants will require
an appropriate conversion), which supports the importance of
the membrane interaction in omiganan's mode of action.
An observed reduction in IL/IW ratios is in agreement with a
preferential interaction of the peptide with the membrane
surface, as this may reflect an exposure of the Trp residues to apolar environment. For the models of biological membranes,
peptide localization was determined with more accuracy by
differential quenching methods, discussed below.
4.2.3. Cholesterol effect on the partition extent
To further assess the action of omiganan towards mammalian
cells, cholesterol was added to the 100% POPC and 1:4 POPG:
POPC model systems (phospholipid:cholesterol ratio of 2:1),
and the presence of specific peptide–sterol interactions were
investigated. These are undesirable interactions because their
occurrence may increase the peptide's partition extent towards
mammalian membranes (as opposed to bacterial ones, which are
sterol-free) and eventually represent an increased toxicity risk,
should the peptide disturb the structural properties that
cholesterol confers to the bilayer [38,39].
Both partition constants for the mammalian membrane
models (inner and outer leaflet) remained within the same order
of magnitude as the 100% POPC, sterol-free system, which is
unsupportive of the cholesterol having, per se, a very strong
interaction with the peptide. The most pronounced consequence
of cholesterol addition was the induction of a gel phase like
behavior (Fig. 2): the partition curves deviated from the
hyperbolic-like progression, indicating the occurrence of self-
quenching, as with the DPPC system. Since cholesterol
condenses liquid crystal bilayers, forming a liquid ordered
phase [40], this observation indicates that omiganan does not
have specific interactions with it, or at least not to a point where
its properties are significantly altered. This was further
demonstrated by testing the effect of cholesterol in the 4:1
POPG:POPC system, which has a higher charge and partition
constant: the same sigmoidal behavior was observed and an
apparently lower extent of partition was observed although it
was impossible to calculate a Kp value because the non-
hyperbolic regime dominated most of the curve (Fig. 2B).
These evidences predict a low cholesterol related toxicity of
omiganan towards human cells, in agreement with its clinical
safety profile [3].
4.3. Membrane saturation studies
The hypothesis of membrane saturation was tested by
titrating LUV suspensions with peptide while monitoring
omiganan's fluorescence intensity. Under the simple partition
model, for a given lipid concentration, the relative proportions
of peptide in and out of the membrane (XL and XW, respectively)
should be constant, independently of overall peptide concentra-
tion changes [23]. In this case, the total fluorescence intensity, I,
will be the sum of IL and IW, weighted, respectively, by XL and
XW [23]. Because IL and IW, are expected to be proportional to
the global peptide concentration, under these conditions I∝[P],
where [P] is the overall peptide concentration. The I vs. [P]
titrations were carried out in the presence of acrylamide, which
is an aqueous phase quencher, to increase the difference
between IL and IW, in order to better identify alterations in the
phase localization of omiganan.
The behavior displayed in the peptide titrations (Fig. 3B) is
consistent with the occurrence of saturation: for low membrane-
Fig. 6. Total peptide and phospholipid concentrations at saturation points for the
4:1 (● or ○) and 2:1 POPG:POPC (▴) systems, together with the respective
fittings to Eq. (5) (solid lines). Saturation points were obtained from the partition
curves at different peptide concentrations (Fig. 3A) (○), or from fluorescence vs.
[omiganan] titrations (Fig. 3B) (●). The concordance between saturation points
from fluorescence intensity vs. [omiganan] plots and from partition curves
supports the relation between the deviations in the latter and membrane
saturation. Obtained saturation proportions (P:L) were 0.17 for the 4:1 POPG:
POPC system and 0.027 for the 2:1 POPG:POPC system; partition constants
were 1.87×105 (but varying between 1.14×105 and 3.98×105 with the
regression associated errors) and (5.2±0.9)×103, respectively.
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rightmost part of the hyperbolic-like I vs. [L] partition curves,
the model of Santos et al. [30] is followed as I increases
proportionally to [P]; however, with the increase of P:L the
membrane will eventually run out of space and any further
added peptide beyond saturation will have to remain in the
aqueous phase; this is corroborated by the second slope being
similar to that of the I vs. [P] curve in the absence of lipid, i.e.,
after the saturation point the system behaves as if no lipid were
present for the peptide to partition to.
The I vs. [P] curve with [L]=0.040 mM has its saturation
point close to [P] ≈7.7 μM (Fig. 3B), which is precisely the
peptide concentration that yields an I vs. [L] curve with a
deviation maximum close to 0.040 mM (Fig. 1C). In other
words, the [P] and [L] values at the saturation point in Fig. 3B
are the same than those at the end of the deviation in Fig. 1C,
which is evidence for a correlation between deviations to
partition curves and saturation.
To further extract information from the saturation phenom-
enon, a relationship between the [P] and [L] values at the
saturation points was devised: at membrane-bound peptide
concentrations below the saturation point it can be assumed that
the partition is dictated by a Nernst formalism, like the one
described by Santos et al. [30]. On the other hand, above the
saturation threshold, the amount of peptide in the lipidic phase
can be expected to be directly proportional to the total volume
of the lipid phase, and thus proportional to the amount of the
lipid itself. The bound peptide fraction above the saturation
point (XL,s) will be given by:
XL;s ¼ rnLnp ¼
r½L
½P ð3Þ
where σ is the P:L proportion in a saturated membrane and nP
and nL are the total number of moles of peptide and
phospholipid, respectively. At the saturation point it can be
assumed that XL,ns=XL,s, XL,ns being the bound peptide fraction
below the saturation point, and consequently:
XL;ns ¼ KpgL½L1þ KpgL½L
¼ r½L½P ¼ XL;s ð4Þ
where XL,ns is defined as by Santos et al. [23]. This equation can
be rearranged to
P½  ¼ r
KpgL
þ r L½  ð5Þ
which defines the total amount of peptide at which a saturation
point occurs as a linear function of the amount of phospholipid in
the system. Besides providing information on the magnitude of
the partition constant, the non-zero intercept indicates that there
is a minimum peptide concentration for saturation to occur,
according to this model. A related equation has been used by Pott
et al. [41] to define the relationship between the global peptide
and phospholipid concentrations at several membrane-critical
proportions of the toxin mellitin. Despite having been deduced
from different starting points, Eq. (5) and the one used by Pott et
al. [41] turn out to be equivalent, with the exception that Eq. (5)directly relates the intercept with the Nernst partition constant.
Fig. 6 represents the saturation point ([P],[L]) pairs for the
POPG:POPC 4:1 and 2:1 systems. Eq. (5) was followed by both
systems and the correlation between membrane saturation and
the deviations to the partition curves was further corroborated
because saturation pairs from partition curves taken at different
peptide concentrations (Fig. 3A) were in agreement with the
saturation pairs obtained from the I vs. [P] curves (Fig. 3B). The
obtained saturation P:L ratios were of 0.17 and 0.027 for the
POPG:POPC 4:1 and 2:1 systems, respectively; this corresponds
to 5.8 and 37.0 phospholipids per peptide at the saturation of
each system.
Although the obtained saturation P:L ratios seem plausible
and robust, the values for Kp have large associated errors since
they are calculated from the reciprocal of a relatively small
intercept, which makes this an unsuitable method for determi-
nation of very large partition constants.
4.4. Partition curve models
The initial deviations in the partition curves could be
successfully attributed to membrane saturation; however, that
explanation is not enough to account for the higher fluorescence
intensities displayed by the saturated systems. In fact, saturation
of the membrane implies that some peptide is being left out of
bilayer interaction; as such, the system fluorescence intensity
should decrease rather than increase. Simulated partition curves
were obtained by setting the system parameters Kp, IL/IW and σ
and taking XL as the minimum between XL,ns and XL,s (Eq. (4)),
i.e., during saturation, the amount of peptide in the membrane is
limited by the saturated conditions, and afterwards by the Nernst
equilibrium. The total fluorescence intensity was obtained by
Fig. 7. (A and B) Simulated partition curves with the occurrence of saturation;
the saturation points correspond to the end of the linear portions of each graph.
Simulation parameters were: σ =0.1; Kp=20000; IW=1; IL=2; in B IS=3 was
used while in A no fluorescence change in IL was associated with saturation (see
the text for the meaning of each parameter). For the three curves in A and B
4 μM, 15 μM and 20 μM peptide concentrations were used (dotted, dashed and
solid lines, respectively); the lowest of these concentrations was chosen to be
below the saturation threshold (6.6 μM, under these conditions). Thinner line
segments represent discontinuities. (C) Fitting of the three-state model to the
8.2 μM omiganan partition curve in 4:1 POPG:POPC; the dotted lines divide the
fitted curve into the three states that were assumed (see text and appendix for a
better description of each state and involved equations, respectively). It can be
seen that the model is able to account for a transition between saturated and non-
saturated states. Obtained system parameters were: Kp=2.23×10
4; σ=0.15;
solubility product=88.4 mM; IL/IW=1.95; IS/IW=2.00. Kp, σ and IL/IW values
are in agreement with the ones determined by other methods.
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simulated curves show that the points of a partition curve that are
under saturation describe a straight line below the non-saturated
hyperbolic behavior (Fig. 7A). The straight initial regime is in
agreement with what was observed for all systems containing
anionic phospholipids, but the increase in fluorescence above
the hyperbole needs further reasoning. Here we explore the
simple hypothesis that, under saturation, omiganan undergoes
some conformation/localization change that leads to an increase
in its fluorescence quantum yield. A second set of simulated
curves (Fig. 7B) were obtained by adding a fourth parameter to
the system: the IS/IW ratio, where IS stands for the limit
fluorescence the system would display if all the peptide were in
the hypothetical saturation conformation/localization. The
fluorescence intensity of the system was calculated as in the
previous simulations, with the exception that IS was used in
place of IL whenever the system was saturated, i.e., XL,s<XL,ns.
Simulated results under this hypothesis predict the occurrence of
a discontinuity in the partition curve at the saturation point (Fig.
7B) and that increasing peptide concentrations will lead to
decreasing slopes of the initial part of the curve, but constant
hyperbolic portions. In addition, higher peptide concentrations
should generate higher maxima before the discontinuity. All
predicted characteristics were respected in partition curves taken
at several peptide concentrations (Fig. 3A) except for the
increase in the maxima and that sharp saturation/non-saturation
transitions were only observed for low peptide concentrations.
Constant post-deviation behaviors were observed, with similar
resulting partition constants (average: (2.38±0.78)×104) and
IL/IW ratios (average: 1.93±0.44), and, as mentioned earlier, the
maxima of the deviations were successfully fit by Eq. (5) (Fig.
6). Even though this model may be too simplistic to fully
describe the system behavior, it shows that saturation-related
conformation/localization changes could be occurring in the
membrane; these may include phenomena such as multi-
merization [42], which could be involved in triggering the
action of omiganan and thus represent the biophysical conditions
behind its MICs against prokaryotes.
Another model was developed to deal with some limitations
of the previous hypothesis, namely, the implicit, and unlikely,
all-at-once conformation/localization changes undergone by the
peptide at the saturation point, which lead to the discontinuity in
the partition curves. In the new approach, these changes were
modeled as a gradual solute saturation in the lipidic phase: for
an increasing peptide concentration in the system, the peptide
molecules will partition according to three different states,
depicted in Figs. 7C and 8. States 1 and 3 correspond to the
notions of, respectively, non-saturation and saturation. In state 2
an intermediate peptide concentration in the membrane is
assumed: after the membrane-bound peptide reaches a critical
concentration – correspondent to an apparent solubility product
of the peptide in the lipidic phase – further interaction with the
membrane requires that some peptide molecules adopt a
saturated, more packed, conformation/localization, with fluor-
escence intensity IS; the rest of the membrane-bound peptide
remains at the concentration corresponding to the apparent
solubility product. Only when all membrane-bound peptidemolecules are arranged in that packed conformation does the
membrane become fully saturated.
The parameters of the new model are all homologous to the
ones of the previous model, plus a fifth parameter, the apparent
solubility product of the peptide. The equations that define the
peptide proportions in each conformation (water dissolved,
Fig. 8. Illustration of the three states of peptide–membrane interaction according to the three-state model. Notice that any depicted conformation or membrane
localization of the peptide in this figure is merely illustrative (see text and appendix for a better description of each state and involved equations, respectively).
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XW, XL, and XS, respectively) are developed in the appendix.
This model was able to predict a transition between saturated
and non-saturated membrane states (Fig. 7C), although the
fitting of state 2 to the experimental data was not very good,
namely due to the straight behavior of the modeled partition
curve. The resulting Kp, σ and IL/IW values (2.23×10
4, 0.15
and 1.95, respectively) are in very close agreement with the
values obtained by the other described method, which indicates
that this model can be used for direct analysis of whole partition
curves with saturation. The remaining two parameters, which
have not been determined by other methods, should be
interpreted with care since they depend largely on the few,
and poorly fit, data points of state 2.
4.5. Membrane localization studies
The membrane localization of omiganan in each of the four
biological model systems was probed using the lipophilic
quenchers 5- and 16-NS. Time resolved fluorescence quenching
data (not shown) were analyzed according to a method
described by Fernandes et al. [43] which yielded two
preferential peptide locations, depending on saturation: the
peptide was found to be preferentially shallow into the bilayer in
non-saturation conditions and very close to the membrane
centre upon saturation. Because four Trp residues contribute to
the global peptide fluorescence, the quenching data reflects an
average localization of the central segment of the peptide.
The results obtained by differential quenching techniques are
in agreement with a saturation-dependent peptide localization
change. In addition, the internalization of the peptide seems a
likely starting point for either membrane translocation or
perturbation. In effect, the coordination of these data with the
obtained different saturation proportions for the models of the
inner and outer leaflets of the bacterial membrane indicates that
there are membrane-bound peptide concentrations at which the
outer leaflet is saturated – the peptide being internalized from
the outer side of the membrane – while the inner leaflet is not –
the peptide being pulled to the inner membrane surface; the
saturation mediated internalization coupled to the different
saturation proportions could thus represent a peptide transloca-
tion mechanism. While speculative, this hypothesis is a
plausible illustration of the possible consequences of membrane
saturation on the antimicrobial action of omiganan.The dependence of the occurrence and intensity of the
partition deviations on the anionic membrane charge can also be
explained by the saturation-driven peptide internalization: when
the system is not saturated, the peptide lies at the bilayer surface
and, as mentioned, is exposed to a charged environment,
resulting in a low IL. Upon internalization, the Trp residues will
be moved away from the charged phospholipid headgroups and
exhibit greater quantum yields, translated in the proposed
models as IS, larger than IL. Peptide internalization in neutral
systems will not lead to such an intense increase in fluorescence
because the shallow peptide was already exposed to a non-
charged environment and IL≈ IS. Thus, partition curves of
neutral systems behave like the modeled curves of Fig. 7A,
whereas increasing anionic surface charge will induce partition
curves like the ones modeled in Fig. 7B and C.
4.6. Partition, saturation and observed MICs
From a macroscopic point of view, the findings on
omiganan–membrane interaction can be correlated to the
MIC: at variance with [44], common MICs are not expected
to be much greater than what is needed for saturation to occur.
Indeed, under the hypothesized conditions by Tossi et al. [44]
(phospholipid area=0.7 nm2; bacterium area=107 nm2;
bacterial concentration=106 bacteria/mL; MIC=1 μM), one
would have an overall lipid concentration accessible to the
peptide of 47 nM (for the sake of simplicity, two phospholipid
monolayers were assumed instead of an outer membrane model
of one monolayer of lipopolysaccharide and another of
phospholipid). According to Eq. (4) (XL,ns member), and
assuming a typical partition constant of 2×104 [36,37], only
0.07% of the total peptide molecules are expected to be engaged
in membrane interaction under these conditions. The aqueous
phase peptide concentration will thus remain virtually unaltered
and approximately equal to the total concentration. If we use the
MIC as the total concentration, by the definition of Kp, the
membrane-bound peptide concentration ([P]L) will be given by
Kp·MIC. With the hypothesized MIC of 1 μM, [P]L will be
20 mM. Multiplication by γL yields a P:L ratio of about 0.015
peptide molecules per lipid, or 66 lipid molecules per peptide,
which is a far lower membrane concentration than the obtained
by the calculations of Tossi et al. [44] (40 peptide molecules per
phospholipid) where implicit infinitely high partition constants
were used. The local membrane concentration of a peptide
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saturation to occur, but by a narrow margin; this means that
peptides with slightly higher Kp's or MICs may indeed be in
saturation: in the previously hypothesized conditions, omiga-
nan, which has a typical MIC50 of about 8 to 16 μM against S.
aureus [2] and a Kp of 23.0×10
3 (Table 1), would have a local
concentration in the membrane of 184 mM, correspondent to
about 7 phospholipid molecules per peptide. This is clearly a
saturation situation and is in close agreement with the obtained
saturation proportions (Fig. 6). This relation between MIC and
saturation supports the existence of possible saturation-
triggered antimicrobial mechanisms not exclusive of omiganan
but potentially shared by many other peptides with high enough
Kp and MIC.
4.7. Omiganan induced leakage of vesicle contents
Lack of leakage is in agreement with previous studies [10]
where the maximum observed effect of membrane perturbation
was depolarization. Together with the high extents of partition
towards the bilayer, the absence of severe membrane perturba-
tion favors a translocation mediated peptide action, in agreement
with the hypothesis from membrane saturation studies.
4.8. Peptidoglycan interaction study
The extent of interaction between omiganan and the bacterial
cell wall was assessed by a method similar to the one used for the
partition curves, with the difference that physical separation by
centrifugation was used and the peptide was quantified in the
supernatant only. This was needed because the peptidoglycan
extracts exhibited intense, Trp characteristic, fluorescence– very
likely from wall proteins that were not washed away during the
extraction process – which prevented an integrated approach.
By comparing the fluorescence intensity of the peptide that
remained on the supernatant (I) with the initial peptide
fluorescence in the absence of added peptidoglycan (IW), the
aqueous phase fraction can be readily calculated:
I=IW ¼ XW ð6Þ
XW can be defined as (1−Xp), where Xp is the peptide fraction
that was held in the peptidoglycan. To relate Xp with the extent
of peptidoglycan partition, it was considered that this interaction
behaved similarly to a solute–resin interaction, like the ones
involved in ion chromatography; the following relationship was
then applicable, as described elsewhere [45]:
Dg ¼
nOmg;PG
mPG
½OmgW
ð7Þ
where Dg (in volume per mass units), also called the column
constant, is a system parameter that, like Kp, dictates the
peptide–peptidoglycan degree of interaction; nOmg,PG is the
number of peptide molecules in the peptidoglycan mesh, mPG is
the mass of the mesh and [Omg]W is the water dissolved peptide
concentration. Dg can be converted to a molar ratio (usuallyrepresented Dv) after multiplication by the fully hydrated
peptidoglycan density (H2O mass excluded) [45]. Obviously,
the peptidoglycan is not a solvent; however, a spatial
concentration of the peptide in the mesh can be considered. A
reported value of 196.1 mg/mL for the S. aureus wall was used
in this conversion [46]. However, due to possible peptidoglycan
volume changes, Dv must be carefully used [46]; it is,
nonetheless, a much more useful parameter than Dg since it
has a more intuitive meaning and can be directly compared to
Kp values.
Because Xp is given by the ratio of the peptidoglycan-bound
peptide and the total amount of peptide, it can be defined as a
function of Dg:
XP ¼ nOmg;PGnOmg;PG þ nOmg;W ¼
DgdCPG
1þ DgdCPG ; ð8Þ
where CPG stands for the mass concentration of the peptidogly-
can and nOmg,W for the moles of aqueous peptide. The
fluorescence intensity is then given by:
I=IW ¼ XW ¼ 1 XPð Þ ¼ 11þ DgdCPG : ð9Þ
A good fit was obtained (Fig. 5) with Dg=15.9±1.1 mL/mg
(Dv= (3.1±0.2)×10
3); which suggests that the omiganan
molecules will be much more concentrated in the mesh than
in the water. Despite this large partition towards the peptido-
glycan, in a biological system the highest local peptide
concentration will still be in the membrane (Kp>Dv), never-
theless, because peptidoglycan occupies a much larger volume
than the bilayer does (typically, 20 to 80 nm thick in gram-
positive bacteria [47], about 5 to 20 times the width of a bilayer)
the relative difference of Kp over Dv (approximately 7 to 13
fold) is compensated for, and the absolute amount of peptide
can be expected to be similar in both locations and possibly
even greater in the cell wall. While these results could, at a first
glance, lead to the conclusion that the cell wall is able to
compete with the membrane for the antibiotic and possibly act
as reservoir/trap that would reduce the peptide's efficiency, it
must not be forgotten that, as mentioned earlier, both the
membrane and the cell wall exist in minute concentrations under
MIC assay conditions, which results in the wall and membrane-
bound peptide fractions being negligible. Under these circum-
stances, both predicted aqueous phase and membrane bound
peptide concentrations should remain the same in the presence or
absence of the cell wall, defeating its role as a peptide trap. The
observed thermodynamic impossibility for the wall to become
such an ionic peptide trap is in agreement with the report that S.
aureus adapt by incorporating D-alanine esters into the teichoic
acid to lower the overall anionic charge of the wall as a means of
repelling cationic antibiotics [48], rather than entrapping them.
This does not invalidate the hypothesis that other components of
the system, such as anionic species in solution, can be involved
in peptide association and consequent reduction of membrane
interaction [44], however, such components must be in a
relatively large concentration for their influence to be sig-
nificant; likewise, other membrane constituents, which are
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partition.
It should also be noted that these findings refer to
thermodynamic properties of the peptide–wall interaction; the
ability, or lack thereof, of the peptidoglycan to restrict the
diffusion of the peptide cannot be inferred from the usedmethod.
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Appendix
The three-state model is defined by the equation sets
described below, where XL,ns, XL,s and XW represent the non-
saturated membrane-bound, the saturated membrane-bound and
the aqueous phase peptide fractions, respectively; [P] and [L]
are the total peptide and lipid concentrations and [L]f is the free
lipid concentration (not involved in saturation); The parameters
Kp, σ and S are the Nernst partition constant, the saturation P:L
ratio and the apparent solubility product of the peptide,
respectively. The total fluorescence intensity I of the system is
given by the weighted sum of the fluorescence contribution of
each peptide population (IW, IL and IS, for the aqueous phase,
non-saturated membrane-bound and saturated membrane-
bound populations, respectively): I=XWIW+XL,nsIL+XL,sIS.
State 1—Low overall peptide concentrations—Because the
membrane-bound peptide concentration is insufficient to cause
saturation, XL,s is zero and no lipid is occupied by saturated
peptide molecules. The peptide fraction in the membrane is
dictated by the partition constant, as in the XL,ns member of Eq.
(4). The set of equations for this state is:
XL;s ¼ 0 ðA1Þ
XW ¼ 1 XL;ns ðA2Þ
XL;ns ¼ KpgL½L1þ KpgL½L
ðA3Þ
½Lf ¼ ½L ðA4Þ
State 2—Intermediate peptide concentrations—The peptide
concentration in the membrane exceeds the threshold of the
solubility product and two populations now coexist in the
membrane: peptide in non-saturated and saturated conforma-
tions/localizations, the concentration of the former being
constant and equal to the solubility product. Assuming, for
simplicity that exchanges between membrane-bound and
aqueous phase peptide concern only the non-saturated form
and still follow the Nernst equilibrium it can be seen that that the
aqueous phase peptide concentration should also be constant
and equal to (S/Kp). Considering that the aqueous phase volumeis approximately equal to the total system volume, XW can be
obtained as:
XW ¼ SKpd½P ðA5Þ
XL,ns can be obtained in a similar manner, but prior to
division by [P], the concentration of non-saturated membrane-
bound peptide molecules over the total volume must be
calculated; this can be done by multiplying S by the membrane
volume and dividing by the total volume (note that the
membrane volume concerns only the portion of the bilayer
that is not saturated):
XL;ns ¼ SdVL;fVtotal½P ðA6Þ
where VL,f is the non-saturated membrane volume and Vtotal is
the total volume of the system. VL,f is given by [L]f·Vtotal·γL,
and thus
XL;ns ¼ Sd ½Lf dgL½P ðA7Þ
[L]f can be calculated from the difference between the global
phospholipid concentration and the concentration of saturation
involved phospholipids. The latter is equal to
XL;s½P
r
, and thus
½Lf ¼ L½  
XL;s½P
r
ðA8Þ
XL,s can be obtained by mass conservation:
XL;s ¼ 1 XW  XL;ns ðA9Þ
However, with only this set of equations, XL,ns is recursively
dependent on itself. Eqs. (A7), (A8) and (A9) can be combined
to yield an independent definition of XL,ns:
XL;ns ¼ Sd gLr Sd gL
½Ld r
½P þ XW  1
 
ðA10Þ
State 3—High overall peptide concentrations—The mem-
brane becomes fully saturated with peptide. Only the aqueous
phase and the saturated conformation/localization peptide
populations coexist; the fraction of peptide in the membrane
is given by the XL,s member of Eq. (4):
XL;s ¼ r½L½P ðA11Þ
XW ¼ 1 XL;s ðA12Þ
XL;ns ¼ 0 ðA13Þ
½Lf ¼ 0 ðA14Þ
The equations for each state were solved for a range of lipid
concentrations and the parameters were fit to experimental data
by a least squares method, based on the Solver add-in of
Microsoft Excel 2003 (Microsoft, Seattle, WA).
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